Company News

Share this article:

Eli Lilly entered into a marketing collaboration with device-maker Medtronic to extend the reach of both companies' diabetes products. Marketing and sales operations at both companies will work together to “develop new educational resources and classes around the initiation and intensive management of insulin, insulin pump therapy and continuous glucose monitoring,” according to a joint release.

 

Novartis acquired the generic injectable cancer drugs business of Austria's EBEWE Pharma for $1.2 billion, cash. EBEWE's products will be incorporated into Novartis's generics unit, Sandoz, which will expand to create a new unit in Unterach, Austria, according to a statement.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.